ClinicalTrials.Veeva

Menu

A Study of the Safety and Efficacy of Venetoclax in Japanese Participants With Relapsed and Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Leukemia) (VENCLL regPMOS)

AbbVie logo

AbbVie

Status

Completed

Conditions

Small Lymphocytic Leukemia (SLL)
Cancer
Chronic Lymphocytic Leukemia (CLL)

Study type

Observational

Funder types

Industry

Identifiers

NCT04198415
P19-830

Details and patient eligibility

About

This study will collect real-world safety and efficacy data from Japanese relapse/refractory chronic lymphocytic leukemia (CLL) and small lymphocytic leukemia (SLL) participants treated with venetoclax.

Enrollment

4 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

-Prescribed and treated with venetoclax

Exclusion criteria

None

Trial design

4 participants in 1 patient group

Venetoclax Participants
Description:
Participants prescribed and treated with venetoclax.

Trial contacts and locations

102

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems